Zebra Technologies
ZBRA
$216.79
-7.43%
Zebra Technologies Corporation is a leading global provider of automatic identification and data capture (AIDC) technology, specializing in barcode printers and scanners, mobile computers, and workflow optimization software. The company is the dominant market leader in enterprise-grade AIDC solutions, serving critical verticals such as retail, transportation logistics, manufacturing, and healthcare with custom solutions designed to improve operational efficiency. The current investor narrative centers on the company's ability to navigate a challenging macroeconomic environment for industrial technology spending, with recent attention focused on its Q4 2025 earnings report where it provided bullish guidance that exceeded analyst expectations, signaling potential for a growth reacceleration despite ongoing margin pressures.…
ZBRA
Zebra Technologies
$216.79
Related headlines
Investment Opinion: Should I buy ZBRA Today?
Rating: Hold. The core thesis is that Zebra Technologies presents a high-risk, high-potential reward situation where severe operational headwinds are balanced by a deeply discounted forward valuation, making it appropriate for patient, risk-tolerant investors to monitor but not compelling enough for a broad Buy recommendation.
The Hold rating is supported by four key data points: 1) The forward P/E of 11.85x is deeply discounted and prices in substantial pessimism, 2) Revenue remains resilient, growing 10.57% YoY in Q4 to $1.475 billion, 3) Free cash flow generation is robust at $831 million TTM, providing a financial safety net, and 4) Analyst sentiment has stabilized post-earnings with no recent downgrades, anchoring an average EPS estimate of $29.40. However, these are counterbalanced by net margin compression to 4.75% and a negative PEG ratio of -1.50.
The two biggest risks that could invalidate this thesis are: 1) Further gross margin erosion below 44%, indicating a structural rather than cyclical problem, and 2) A deceleration in revenue growth below mid-single digits, signaling market share loss. This Hold would upgrade to a Buy if the forward P/E compresses further toward 10x while margins show sequential stabilization, or if Q1 2026 results demonstrate clear progress on gross margin recovery. It would downgrade to a Sell if revenue growth turns negative or liquidity concerns intensify (current ratio falls below 0.9). Relative to its own history and the current growth profile, the stock is fairly valued to slightly undervalued on a forward basis, but overvalued on a trailing basis given the earnings collapse.
Sign up to view all
ZBRA 12-Month Price Forecast
The AI assessment is neutral, reflecting a stalemate between compelling valuation and deteriorating fundamentals. The forward P/E of 11.85x is deeply discounted and suggests most bad news is priced in, offering a margin of safety. However, the severe margin compression witnessed in Q4 2025 cannot be ignored and poses a direct threat to the earnings needed to justify even that low multiple. The strong free cash flow is a critical positive, but the stock's high beta means it will remain volatile. The stance would upgrade to bullish on clear evidence of margin stabilization in the next quarterly report, supported by management's reaffirmed guidance. It would turn bearish if the next earnings release shows further margin degradation or a guidance cut, confirming the operational challenges are worsening.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Zebra Technologies's 12-month outlook, with a consensus price target around $281.83 and implied upside of +30.0% versus the current price.
Average Target
$281.83
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$173 - $282
Analyst target range
Analyst coverage for Zebra Technologies is limited, with only 5 analysts providing estimates, indicating this is a mid-cap stock with less widespread institutional following, which can contribute to higher volatility. The consensus sentiment, based on recent institutional ratings, leans cautiously optimistic, with firms like Barclays and Baird maintaining 'Overweight' or 'Outperform' ratings, while Citigroup and Truist Securities have 'Neutral' or 'Hold' stances. The average revenue estimate for the next period is approximately $7.26 billion, with an average EPS estimate of $29.40.
The target price range implied by the EPS estimates (using the forward P/E as a rough proxy) suggests a wide dispersion of outcomes, reflecting high uncertainty around the company's near-term execution and macro sensitivity. A high target would assume successful margin recovery and a return to stronger growth, justifying multiple expansion. Conversely, a low target would price in continued margin pressure, weak enterprise spending, and potential market share loss. The recent pattern of analyst actions shows stability, with no downgrades in the latest batch of reports following the Q4 earnings, suggesting the initial negative reaction to margin compression may have been absorbed, and analysts are taking a wait-and-see approach on the company's guidance for improvement.
Bulls vs Bears: ZBRA Investment Factors
The investment debate for Zebra Technologies centers on a stark conflict between deteriorating fundamentals and a compelling valuation reset. The bear case is powerfully supported by severe margin compression, high volatility, and weak near-term liquidity. However, the bull case finds strength in the company's robust free cash flow, dominant market position, and a forward P/E of 11.85x that prices in significant pessimism. Currently, the bearish evidence from operational execution (margins) carries more weight than the bullish valuation argument. The single most important tension is whether management can successfully execute a margin recovery to validate the low forward earnings multiple. If margins stabilize or improve, the stock could rerate sharply higher; if compression continues, the attractive forward multiple will prove to be a value trap.
Bullish
- Strong Free Cash Flow Generation: Zebra generated $831 million in trailing twelve-month free cash flow, providing significant financial flexibility to navigate challenges, invest in growth, and service its debt. This robust cash generation is a key pillar of financial strength, especially when net income is under pressure.
- Attractive Forward Valuation: The stock trades at a forward P/E of 11.85x, which is a significant discount to its trailing P/E of 29.45x and suggests the market is pricing in a substantial earnings recovery. This forward multiple appears reasonable if the company can meet analyst EPS expectations of $29.40, implying a potential re-rating opportunity.
- Recent Positive Momentum & Guidance: The stock has gained 11.76% over the past three months, showing stabilization after a severe downtrend. This aligns with the company's Q4 2025 earnings report, which provided bullish guidance that exceeded analyst expectations, signaling potential for growth reacceleration.
- Dominant Market Leadership: As the largest global provider of enterprise AIDC technology, Zebra holds a strong competitive position in critical verticals like retail, logistics, and healthcare. This market leadership provides a durable revenue base of $1.475 billion in Q4, growing at 10.57% YoY despite macro headwinds.
Bearish
- Severe Margin Compression: Q4 2025 net margin collapsed to 4.75% from 12.22% a year ago, with gross margin falling to 44.61% from 48.58%. This sharp profitability decline, driven by rising costs or competitive pressures, is the single biggest fundamental concern and directly impacts earnings power.
- High Volatility & Underperformance: With a beta of 1.624, ZBRA is 62% more volatile than the market, explaining its amplified 41.62% maximum drawdown. The stock is down 15.65% over the past year, severely underperforming the S&P 500's 27.04% gain, indicating persistent negative sentiment.
- Weak Liquidity & Earnings Growth: A current ratio of 0.97 indicates potential near-term liquidity strain. Furthermore, the negative PEG ratio of -1.50 signals that the stock's valuation is not justified by near-term earnings growth expectations, highlighting skepticism about a quick profit recovery.
- Macro Sensitivity & Spending Risk: Recent news highlights stubborn inflation keeping interest rates high, which pressures enterprise technology spending. As an industrial tech provider, Zebra's growth is highly correlated to capital expenditure cycles in its core verticals, creating a headwind.
ZBRA Technical Analysis
Zebra Technologies is in a pronounced downtrend, with the stock price down 15.65% over the past year, significantly underperforming the broader market, which is up 27.04%. The current price of $245.48 is trading near the lower end of its 52-week range, approximately 30% above its 52-week low of $199.05 but a substantial 30% below its 52-week high of $352.66. This positioning suggests the stock is in a deep corrective phase, having experienced a maximum drawdown of -41.62%, and is currently in a phase of consolidation after a severe decline, presenting a potential value opportunity if fundamentals stabilize, but also carrying the risk of further weakness if the downtrend resumes.
The stock's recent momentum shows signs of stabilization and a modest rebound from its lows, with a 7.48% gain over the past month and an 11.76% gain over the past three months. This positive short-term momentum diverges sharply from the negative one-year trend, indicating a potential bottoming process or a bear market rally. However, the stock's beta of 1.624 indicates it is 62% more volatile than the S&P 500, which explains its amplified moves and suggests the recent rebound could be volatile and subject to reversal if market sentiment sours.
Key technical support is anchored at the 52-week low of $199.05, which represents a critical level; a decisive break below this could signal a new leg down in the downtrend. Immediate resistance lies near the recent high of $274.15 from mid-February, and a sustained move above that level would be necessary to signal a more meaningful trend reversal. The stock's high beta of 1.624 underscores its high-risk, high-volatility profile, which investors must factor into position sizing, as it is likely to experience larger swings than the overall market during periods of uncertainty.
Beta
1.63
1.63x market volatility
Max Drawdown
-41.6%
Largest decline past year
52-Week Range
$199-$353
Price range past year
Annual Return
-27.6%
Cumulative gain past year
| Period | ZBRA Return | S&P 500 |
|---|---|---|
| 1m | -0.1% | -1.9% |
| 3m | +6.2% | +8.9% |
| 6m | -19.2% | +6.4% |
| 1y | -27.6% | +20.3% |
| ytd | -12.7% | +6.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ZBRA Fundamental Analysis
Zebra's revenue trajectory shows resilience but decelerating growth. For Q4 2025, the company reported revenue of $1.475 billion, representing a year-over-year growth of 10.57%. However, examining the sequential quarterly trend from the provided data reveals a pattern: revenue grew from $1.175B in Q1 2024 to a peak of $1.475B in Q4 2025, but the most recent quarter's growth rate of 10.57% is a deceleration from the higher growth rates seen in prior periods. The revenue is split between its two segments: Enterprise Visibility & Mobility (EVM) at $865 million and Asset Intelligence & Tracking (AIT) at $455 million, indicating the EVM segment is the larger revenue driver.
Profitability has come under significant pressure, with margins compressing notably in the latest quarter. Q4 2025 net income was $70 million, a sharp decline from $163 million in the year-ago quarter, and the net margin contracted to 4.75% from 12.22%. Gross margin for the quarter was 44.61%, down from 48.58% a year ago, and the operating margin fell to 15.05% from 16.87%. This sequential compression in both gross and operating margins indicates rising cost pressures or competitive pricing dynamics that are squeezing profitability, a key concern for investors.
The balance sheet and cash flow picture is mixed. The company maintains a moderate debt-to-equity ratio of 0.78, indicating a reasonable level of financial leverage. However, the current ratio of 0.97 suggests potential liquidity strain, as it is below 1.0. On a positive note, trailing twelve-month free cash flow is a robust $831 million, providing significant financial flexibility. The return on equity (ROE) of 11.68% is respectable but has declined from higher levels in previous quarters, reflecting the recent pressure on net income. The company's ability to generate strong operating cash flow ($357 million in Q4) helps offset the weaker current ratio and supports its ability to service debt and fund operations.
Quarterly Revenue
$1.5B
2025-12
Revenue YoY Growth
+0.10%
YoY Comparison
Gross Margin
+0.44%
Latest Quarter
Free Cash Flow
$831000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ZBRA Overvalued?
Given that Zebra reported positive net income of $70 million in its latest quarter, the primary valuation metric selected is the Price-to-Earnings (P/E) ratio. The stock trades at a trailing P/E of 29.45x, which is significantly higher than its forward P/E of 11.85x. This substantial gap indicates the market is pricing in a strong recovery in earnings over the next twelve months, as the forward multiple implies much higher expected profits.
Compared to industry averages, Zebra's valuation presents a complex picture. Its trailing P/E of 29.45x is elevated, but the forward P/E of 11.85x appears more reasonable if earnings projections are met. The Price-to-Sales (P/S) ratio of 2.29 and EV/Sales of 2.62 provide alternative views, suggesting the market values the company at just over 2x its sales. The negative PEG ratio of -1.50, driven by negative earnings growth expectations in the near term, signals that the stock's valuation is not justified by its growth profile based on that metric, highlighting the market's skepticism about near-term profit expansion.
Historically, Zebra's current trailing P/E of 29.45x sits below its own historical range observed in the provided data, which has seen peaks above 40x and even over 200x during periods of minimal earnings. The current multiple is a significant compression from levels above 30x seen in late 2024 and early 2025, reflecting the market's downward re-rating due to margin compression and growth concerns. Trading near the lower end of its historical valuation band suggests the stock is pricing in substantial pessimism, potentially offering a margin of safety if the company can execute a turnaround, but also indicating that expectations for a rapid earnings recovery are low.
PE
29.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -202x~206x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced, centered on a dramatic collapse in profitability. Q4 2025 net income fell 57% year-over-year to $70 million, with net margin contracting from 12.22% to 4.75%. This margin pressure, if sustained, threatens the company's ability to grow earnings and justify its valuation. Furthermore, a current ratio of 0.97 indicates potential liquidity strain in meeting short-term obligations, though this is mitigated by strong operating cash flow of $357 million in the quarter. Revenue concentration in cyclical verticals like retail and manufacturing also exposes the company to downturns in enterprise spending.
Market & Competitive Risks are elevated due to Zebra's high valuation sensitivity and macro exposure. The stock's beta of 1.624 means it is highly correlated to market swings, and recent news of persistent inflation suggests a higher-for-longer interest rate environment that compresses multiples for industrial tech stocks. While Zebra is the market leader, competitive disruption from adjacent technologies or more agile competitors poses a constant threat. The stock's trailing P/E of 29.45x, though below its historical peak, remains elevated relative to its current growth profile, creating valuation compression risk if earnings disappoint.
Worst-Case Scenario involves a continuation of the current downtrend fueled by a failure to arrest margin decline, coupled with a broader economic slowdown that curtails enterprise IT budgets. This could lead to consecutive earnings misses, analyst downgrades, and a loss of investor confidence. In this adverse scenario, the stock could retest and break below its critical 52-week low of $199.05, potentially falling towards levels implied by its maximum drawdown of -41.62%. From the current price of $245.48, this represents a realistic downside of approximately -19% to the 52-week low, with further declines possible if the fundamental deterioration accelerates.
FAQ
The key risks are, in order of severity: 1) Financial Risk: Continued margin compression, as seen with the net margin falling to 4.75% in Q4, which directly erodes earnings. 2) Liquidity Risk: A current ratio of 0.97 indicates potential strain in meeting short-term obligations. 3) Market Risk: High beta of 1.624 means the stock is 62% more volatile than the market, amplifying losses during downturns. 4) Macroeconomic Risk: Sensitivity to enterprise spending cycles in retail, manufacturing, and logistics, which could weaken if the economy slows.
The 12-month forecast for ZBRA is wide-ranging, reflecting high uncertainty. The base case (55% probability) sees the stock trading between $260 and $300, driven by stabilized margins and single-digit revenue growth. The bull case (25% probability) targets $330 to $370 on successful margin recovery and growth reacceleration. The bear case (20% probability) warns of a drop to $190-$220 if operational deterioration continues. The most likely outcome is the base case, which assumes management can halt the margin decline but not fully restore prior profitability levels in the near term.
ZBRA's valuation sends mixed signals, creating a dichotomy. On a trailing basis, with a P/E of 29.45x and negative earnings growth (PEG -1.50), the stock appears overvalued relative to its current profitability. However, the forward P/E of 11.85x is deeply discounted and suggests the stock is undervalued if the company meets analyst EPS estimates of $29.40. This gap implies the market is pricing in significant skepticism about future earnings. Compared to its own historical multiples, which have been above 30x, the current trailing multiple suggests a valuation reset has already occurred.
ZBRA is a high-risk, high-potential reward stock that may be a good buy only for specific investors. For risk-tolerant investors seeking a turnaround story, the forward P/E of 11.85x offers a compelling valuation if the company can stabilize its margins. However, given the severe 57% drop in Q4 net income and ongoing margin pressures, it is not a good buy for conservative or income-focused investors. The decision hinges entirely on one's confidence in management's ability to execute a profitability recovery in the face of potential macroeconomic headwinds.
ZBRA is not suitable for short-term trading due to its high volatility (beta 1.624) and lack of near-term positive catalysts; it is a story stock in transition. It is more appropriate for a medium-to-long-term investment horizon of 2-3 years, allowing time for the company's margin recovery plan to play out and for the valuation discount to potentially close. The stock pays no dividend, eliminating it as an income play. Given the operational turnaround required, investors must be prepared for significant volatility and should have a horizon long enough to weather quarterly earnings fluctuations.